Innogenetics N.V.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 25100
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 18188
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1485
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1188
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 10157
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
C07K PEPTIDES 6130
 
  
 
F15B SYSTEMS ACTING BY MEANS OF FLUIDS IN GENERAL; FLUID-PRESSURE ACTUATORS, e.g. SERVOMOTORS; DETAILS OF FLUID-PRESSURE SYSTEMS, NOT OTHERWISE PROVIDED FOR 144

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8278432 HBV drug resistance methodsMar 29, 02Oct 02, 12[C07H, C12Q]
7935490 Immunodiagnostic assays using reducing agentsAug 02, 06May 03, 11[C12Q, G01N]
7422848 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereofMar 15, 06Sep 09, 08[C12Q]
7387879 Diagnosis of tauopathiesOct 09, 03Jun 17, 08[G01N]
7313357 Method for typing and detecting HBVJun 04, 03Dec 25, 07[C12Q]
7255997 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsAug 15, 00Aug 14, 07[G01N]
7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsJul 06, 01Mar 27, 07[A61K]
7196183 Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agentAug 29, 02Mar 27, 07[C07H]
7157226 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsApr 27, 94Jan 02, 07[C12Q]
7129337 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agentsOct 23, 95Oct 31, 06[C07H]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0171,656 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGIONAbandonedMar 06, 13Jul 04, 13[C12Q]
8426129 Method for typing HLA allelesExpiredApr 14, 08Apr 23, 13[C07H, C12Q, C12P]
8343493 Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugsExpiredOct 24, 08Jan 01, 13[A61K, C12P, C12N, G01N, C07K]
8163873 Isolated microtubule-associated protein tau peptides and kitExpiredNov 10, 08Apr 24, 12[A61K]
8101351 Process for typing of HCV isolatesExpiredJul 12, 07Jan 24, 12[C07H, C12Q]
2011/0136,678 METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS3/4A GENOMIC REGIONAbandonedOct 19, 07Jun 09, 11[C12Q, C12P, C12N, C40B]
2011/0020,803 MARKERS FOR THE PROGNOSIS OF LUNG FUNCTION AND COLONIZATION WITH AN INFECTIOUS AGENTAbandonedSep 29, 08Jan 27, 11[C12Q]
7855052 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agentsExpiredNov 30, 06Dec 21, 10[C07H, C12Q, C12P, C12N]
2009/0325,145 METHODOLOGY FOR ANALYSIS OF SEQUENCE VARIATIONS WITHIN THE HCV NS5B GENOMIC REGIONAbandonedOct 19, 07Dec 31, 09[C12Q, C12P, C12N]
2009/0191,558 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF SERRATIA SPECIES USING THE SPACER REGIONAbandonedDec 09, 08Jul 30, 09[C07H, C12Q, G01N]
2009/0098,558 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF PROTEUS SPECIES USING THE SPACER REGIONAbandonedOct 16, 08Apr 16, 09[C12Q, C12N]
2009/0068,651 Method for the detection of the antibiotic resistance spectrum of mycobacterium speciesAbandonedJun 27, 07Mar 12, 09[C07H, C12Q]
2009/0017,456 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF EUBACTERIAL TAXA USING A HYBRIDIZATION ASSAYAbandonedMar 10, 08Jan 15, 09[C07H, C12Q]
2008/0274,144 HCV E1 COMPRISING SPECIFIC DISULFIDE BRIDGESAbandonedMar 24, 08Nov 06, 08[A61K, C12N, G01N, A61P, C07K]
7413741 HCV E1 comprising specific disulfide bridgesExpiredMar 08, 05Aug 19, 08[A61K]
7390623 Detection and identification of staphylococcus aureus and epidermidis using the 16S-23S rRNA spacerExpiredJul 21, 04Jun 24, 08[C12Q]
2008/0138,894 PURIFIED HEPATITIS C VIRUS ENVELOPE PROTEINS FOR DIAGNOSTIC AND THERAPEUTIC USEAbandonedFeb 23, 07Jun 12, 08[C12N]
2008/0131,888 Nucleic Acid Variants in the Ficolin Genes Associated with Altered Innate ImmunityAbandonedJan 20, 06Jun 05, 08[C07H, C12Q]
7279170 32-kDa protein derived from Mycobacterium tuberculosis and related peptidesExpiredJun 22, 06Oct 09, 07[A61K]
7258977 Process for typing of HCV isolatesExpiredApr 14, 03Aug 21, 07[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.